The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?

Bibliography

• Apstein CS, Deckelbaum L, Mueller M, et al. Graded global ischemia and reperfusion. Cardiac function and lactate metabolism. Circulation 1977;55(6):864-72
   PubMed Web of Science ®Google Scholar
• Hess ML, Manson NH. Molecular oxygen: friend and foe. The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J Mol Cell Cardiol 1984;16(11):969-85
   PubMed Web of Science ®Google Scholar
• McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312(3):159-63
   PubMed Web of Science ®Google Scholar
• Pacher P, Hasko G. Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 2008;153(2):252-62
   PubMed Web of Science ®Google Scholar
• Vasileiou I, Fotopoulou G, Matzourani M, et al. Evidence for the involvement of cannabinoid receptors’ polymorphisms in the pathophysiology of human diseases. Expert Opin Ther Targets 2013;17(4):363-77
   PubMed Web of Science ®Google Scholar
• Zogopoulos P, Vasileiou I, Patsouris E, Theocharis SE. The role of endocannabinoids in pain modulation. Fundam Clin Pharmacol 2013;27(1):64-80
   PubMed Web of Science ®Google Scholar
• Pacher P, Kunos G. Modulating the endocannabinoid system in human health and disease--successes and failures. FEBS J 2013;280(9):1918-43
   PubMed Web of Science ®Google Scholar
• Zogopoulos P, Korkolopoulou P, Patsouris E, Theocharis S. The antitumor action of cannabinoids on glioma tumorigenesis. Histol Histopathol 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Steffens S, Pacher P. Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies. Br J Pharmacol 2012;167(2):313-23
   PubMed Web of Science ®Google Scholar
• Guzman M, Sanchez C, Galve-Roperh I. Cannabinoids and cell fate. Pharmacol Ther 2002;95(2):175-84
   PubMed Web of Science ®Google Scholar
• Bisogno T, Martire A, Petrosino S, et al. Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington’s disease. Neurochem Int 2008;52(1-2):307-13
   PubMed Web of Science ®Google Scholar
• Bari M, Battista N, Fezza F, et al. New insights into endocannabinoid degradation and its therapeutic potential. Mini Rev Med Chem 2006;6(3):257-68
   PubMed Web of Science ®Google Scholar
• Porter AC, Sauer JM, Knierman MD, et al. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 2002;301(3):1020-4
   PubMed Web of Science ®Google Scholar
• Calignano A, La Rana G, Giuffrida A, Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature 1998;394(6690):277-81
   PubMed Web of Science ®Google Scholar
• Mackie K. Cannabinoid receptors: where they are and what they do. J Neuroendocrinol 2008;20(Suppl 1):10-14
   PubMedGoogle Scholar
• Di Marzo V, Petrosino S. Endocannabinoids and the regulation of their levels in health and disease. Curr Opin Lipidol 2007;18(2):129-40
   PubMed Web of Science ®Google Scholar
• Pertwee RG. Pharmacological actions of cannabinoids. Handb Exp Pharmacol 2005(168):1-51
   PubMedGoogle Scholar
• Szoke E, Balla Z, Csernoch L, et al. Interacting effects of capsaicin and anandamide on intracellular calcium in sensory neurones. Neuroreport 2000;11(9):1949-52
   PubMed Web of Science ®Google Scholar
• Shen M, Thayer SA. The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons. Brain Res 1998;783(1):77-84
   PubMed Web of Science ®Google Scholar
• Nicholson RA, Liao C, Zheng J, et al. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. Brain Res 2003;978(1-2):194-204
   PubMed Web of Science ®Google Scholar
• De Petrocellis L, Vellani V, Schiano-Moriello A, et al. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. J Pharmacol Exp Ther 2008;325(3):1007-15
   PubMed Web of Science ®Google Scholar
• Woelkart K, Salo-Ahen OM, Bauer R. CB receptor ligands from plants. Curr Top Med Chem 2008;8(3):173-86
   PubMed Web of Science ®Google Scholar
• Ashton JC. The atypical cannabinoid O-1602: targets, actions, and the central nervous system. Cent Nerv Syst Agents Med Chem 2012;12(3):233-9
   PubMedGoogle Scholar
• Han S, Thatte J, Buzard DJ, Jones RM. Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists. J Med Chem 2013;56(21):8224-56
   PubMed Web of Science ®Google Scholar
• Bikis C, Moris D, Vasileiou I, et al. FAK/Src family of kinases: protective or aggravating factor for ischemia reperfusion injury in nervous system? Expert Opin Ther Targets 2015;19(4):539-49
   PubMed Web of Science ®Google Scholar
• Chan PH. Oxygen radicals in focal cerebral ischemia. Brain Pathol 1994;4(1):59-65
   PubMed Web of Science ®Google Scholar
• Kinouchi H, Epstein CJ, Mizui T, et al. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci USA 1991;88(24):11158-62
   PubMed Web of Science ®Google Scholar
• Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004;4(3):181-9
   PubMed Web of Science ®Google Scholar
• Littauer A, de Groot H. Release of reactive oxygen by hepatocytes on reoxygenation: three phases and role of mitochondria. Am J Physiol 1992;262(6 Pt 1):G1015-20
   PubMed Web of Science ®Google Scholar
• Toledo-Pereyra LH, Lopez-Neblina F, Toledo AH. Protein kinases in organ ischemia and reperfusion. J Invest Surg 2008;21(4):215-26
   PubMed Web of Science ®Google Scholar
• Yang S, Yip R, Polena S, et al. Reactive oxygen species increased focal adhesion kinase production in pulmonary microvascular endothelial cells. Proc West Pharmacol Soc 2004;47:54-6
   PubMedGoogle Scholar
• Wang PF, Jiang LS, Bu J, et al. Cannabinoid-2 receptor activation protects against infarct and ischemia-reperfusion heart injury. J Cardiovasc Pharmacol 2012;59(4):301-7
   PubMed Web of Science ®Google Scholar
• Zhang M, Martin BR, Adler MW, et al. Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model. J Cereb Blood Flow Metab 2007;27(7):1387-96
   PubMed Web of Science ®Google Scholar
• Zogopoulos P, Vasileiou I, Patsouris E, Theocharis S. The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects. J Appl Toxicol 2013;33(4):246-64
   PubMed Web of Science ®Google Scholar
• Feizi A, Jafari MR, Hamedivafa F, et al. The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney. Exp Toxicol Pathol 2008;60(4-5):405-10
   PubMed Web of Science ®Google Scholar
• Fouad AA, Al-Mulhim AS, Jresat I. Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats. Life Sci 2012;91(7-8):284-92
   PubMed Web of Science ®Google Scholar
• Batkai S, Mukhopadhyay P, Horvath B, et al. Delta8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors. Br J Pharmacol 2012;165(8):2450-61
   PubMed Web of Science ®Google Scholar
• Batkai S, Osei-Hyiaman D, Pan H, et al. Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. FASEB J 2007;21(8):1788-800
   PubMed Web of Science ®Google Scholar
• Horvath B, Magid L, Mukhopadhyay P, et al. A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury. Br J Pharmacol 2012;165(8):2462-78
   PubMed Web of Science ®Google Scholar
• Rodriguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, et al. The endocannabinoid system: physiology and pharmacology. Alcohol Alcohol 2005;40(1):2-14
   PubMed Web of Science ®Google Scholar
• Bosier B, Muccioli GG, Hermans E, Lambert DM. Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities. Biochem Pharmacol 2010;80(1):1-12
   PubMed Web of Science ®Google Scholar
• Klein TW, Newton C, Larsen K, et al. The cannabinoid system and immune modulation. J Leukoc Biol 2003;74(4):486-96
   PubMed Web of Science ®Google Scholar
• Derocq JM, Jbilo O, Bouaboula M, et al. Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation. J Biol Chem 2000;275(21):15621-8
   PubMed Web of Science ®Google Scholar
• Rajesh M, Mukhopadhyay P, Batkai S, et al. CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion. Am J Physiol Heart Circ Physiol 2007;293(4):H2210-18
   PubMed Web of Science ®Google Scholar
• Schuehly W, Paredes JM, Kleyer J, et al. Mechanisms of osteoclastogenesis inhibition by a novel class of biphenyl-type cannabinoid CB(2) receptor inverse agonists. Chem Biol 2011;18(8):1053-64
   PubMed Web of Science ®Google Scholar
• Zoratti C, Kipmen-Korgun D, Osibow K, et al. Anandamide initiates Ca(2+) signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells. Br J Pharmacol 2003;140(8):1351-62
   PubMed Web of Science ®Google Scholar
• Mackie K, Stella N. Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J 2006;8(2):E298-306
   PubMed Web of Science ®Google Scholar
• Sang N, Zhang J, Chen C. COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity. J Neurochem 2007;102(6):1966-77
   PubMed Web of Science ®Google Scholar
• Nirodi CS, Crews BC, Kozak KR, et al. The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells. Proc Natl Acad Sci USA 2004;101(7):1840-5
   PubMed Web of Science ®Google Scholar
• Breivogel CS, Childers SR, Deadwyler SA, et al. Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J Neurochem 1999;73(6):2447-59
   PubMed Web of Science ®Google Scholar
• Smith TH, Sim-Selley LJ, Selley DE. Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery? Br J Pharmacol 2010;160(3):454-66
   PubMed Web of Science ®Google Scholar
• Shoemaker JL, Joseph BK, Ruckle MB, et al. The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors. J Pharmacol Exp Ther 2005;314(2):868-75
   PubMed Web of Science ®Google Scholar
• Grimsey NL, Goodfellow CE, Dragunow M, Glass M. Cannabinoid receptor 2 undergoes Rab5-mediated internalization and recycles via a Rab11-dependent pathway. Biochim Biophys Acta 2011;1813(8):1554-60
   PubMed Web of Science ®Google Scholar
• Atwood BK, Mackie K. CB2: a cannabinoid receptor with an identity crisis. Br J Pharmacol 2010;160(3):467-79
   PubMed Web of Science ®Google Scholar
• Pazos MR, Mohammed N, Lafuente H, et al. Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors. Neuropharmacology 2013;71:282-91
   PubMed Web of Science ®Google Scholar
• Pazos MR, Cinquina V, Gomez A, et al. Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function. Neuropharmacology 2012;63(5):776-83
   PubMed Web of Science ®Google Scholar
• Sun S, Chen X, Gao Y, et al. Mn-SOD upregulation by electroacupuncture attenuates ischemic oxidative damage via CB1R-mediated STAT3 phosphorylation. Mol Neurobiol 2014. [ Epub ahead of print]
   Google Scholar
• Zhou H, Zhang Z, Wei H, et al. Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats. Brain Res 2013;1529:154-64
   PubMed Web of Science ®Google Scholar
• Ma L, Zhu Z, Zhao Y, et al. Cannabinoid receptor type 2 activation yields delayed tolerance to focal cerebral ischemia. Curr Neurovasc Res 2011;8(2):145-52
   PubMed Web of Science ®Google Scholar
• Wei H, Yao X, Yang L, et al. Glycogen synthase kinase-3beta is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke. Mol Neurobiol 2014;49(1):326-36
   PubMed Web of Science ®Google Scholar
• Kockeritz L, Doble B, Patel S, Woodgett JR. Glycogen synthase kinase-3--an overview of an over-achieving protein kinase. Curr Drug Targets 2006;7(11):1377-88
   PubMed Web of Science ®Google Scholar
• Dash PK, Johnson D, Clark J, et al. Involvement of the glycogen synthase kinase-3 signaling pathway in TBI pathology and neurocognitive outcome. PLoS ONE 2011;6(9):e24648
   PubMed Web of Science ®Google Scholar
• Simao F, Matte A, Pagnussat AS, et al. Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3beta and CREB through PI3-K/Akt pathways. Eur J Neurosci 2012;36(7):2899-905
   PubMed Web of Science ®Google Scholar
• Du J, Wang Q, Hu B, et al. Involvement of ERK 1/2 activation in electroacupuncture pretreatment via cannabinoid CB1 receptor in rats. Brain Res 2010;1360:1-7
   PubMed Web of Science ®Google Scholar
• Pinar-Sueiro S, Zorrilla Hurtado JA, Veiga-Crespo P, et al. Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat. Exp Eye Res 2013;110:55-8
   PubMed Web of Science ®Google Scholar
• Viveros MP, Marco EM, Llorente R, Lamota L. The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: a possible neural substrate for functional interactions. Behav Pharmacol 2007;18(5-6):375-89
   PubMed Web of Science ®Google Scholar
• Gamaleddin I, Wertheim C, Zhu AZ, et al. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking. Addict Biol 2012;17(1):47-61
   PubMed Web of Science ®Google Scholar
• Chen Y, Nie H, Tian L, et al. Nicotine-induced neuroprotection against ischemic injury involves activation of endocannabinoid system in rats. Neurochem Res 2013;38(2):364-70
   PubMed Web of Science ®Google Scholar
• Sun J, Fang Y, Chen T, et al. WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination. Brain Res 2013;1491:225-35
   PubMed Web of Science ®Google Scholar
• Hu B, Wang Q, Chen Y, et al. Neuroprotective effect of WIN 55,212-2 pretreatment against focal cerebral ischemia through activation of extracellular signal-regulated kinases in rats. Eur J Pharmacol 2010;645(1-3):102-7
   PubMed Web of Science ®Google Scholar
• Zhang M, Mahadevan A, Amere M, et al. Unique effects of compounds active at both cannabinoid and serotonin receptors during stroke. Transl Stroke Res 2012;3(3):348-56
   PubMedGoogle Scholar
• Su B, Dong H, Ma R, et al. Cannabinoid 1 receptor mediation of spinal cord ischemic tolerance induced by limb remote ischemia preconditioning in rats. J Thorac Cardiovasc Surg 2009;138(6):1409-16
   PubMed Web of Science ®Google Scholar
• Gasperi V, Evangelista D, Chiurchiu V, et al. 2-Arachidonoylglycerol modulates human endothelial cell/leukocyte interactions by controlling selectin expression through CB1 and CB2 receptors. Int J Biochem Cell Biol 2014;51:79-88
   PubMedGoogle Scholar
• Heinel LA, Rubin S, Rosenwasser RH, et al. Leukocyte involvement in cerebral infarct generation after ischemia and reperfusion. Brain Res Bull 1994;34(2):137-41
   PubMed Web of Science ®Google Scholar
• Shmist YA, Goncharov I, Eichler M, et al. Delta-9-tetrahydrocannabinol protects cardiac cells from hypoxia via CB2 receptor activation and nitric oxide production. Mol Cell Biochem 2006;283(1-2):75-83
   PubMed Web of Science ®Google Scholar
• Gonzalez C, Herradon E, Abalo R, et al. Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia-reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS. Diabetes Metab Res Rev 2011;27(4):331-40
   PubMed Web of Science ®Google Scholar
• Li Q, Wang F, Zhang YM, et al. Activation of cannabinoid type 2 receptor by JWH133 protects heart against ischemia/reperfusion-induced apoptosis. Cell Physiol Biochem 2013;31(4-5):693-702
   PubMed Web of Science ®Google Scholar
• Li Q, Guo HC, Maslov LN, et al. Mitochondrial permeability transition pore plays a role in the cardioprotection of CB2 receptor against ischemia-reperfusion injury. Can J Physiol Pharmacol 2014;92(3):205-14
   PubMed Web of Science ®Google Scholar
• Li Q, Cui N, Du Y, et al. Anandamide reduces intracellular Ca2+ concentration through suppression of Na+/Ca2+ exchanger current in rat cardiac myocytes. PLoS One 2013;8(5):e63386
   PubMedGoogle Scholar
• Duerr GD, Heinemann JC, Suchan G, et al. The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy. Basic Res Cardiol 2014;109(4):425
   PubMed Web of Science ®Google Scholar
• Li Q, Shi M, Li B. Anandamide enhances expression of heat shock protein 72 to protect against ischemia-reperfusion injury in rat heart. J Physiol Sci 2013;63(1):47-53
   PubMed Web of Science ®Google Scholar
• Cappellano G, Uberti F, Caimmi PP, et al. Different expression and function of the endocannabinoid system in human epicardial adipose tissue in relation to heart disease. Can J Cardiol 2013;29(4):499-509
   PubMed Web of Science ®Google Scholar
• Cao Z, Mulvihill MM, Mukhopadhyay P, et al. Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice. Gastroenterology 2013;144(4):808-17; e15
   PubMed Web of Science ®Google Scholar
• Pacher P, Gao B. Endocannabinoids and liver disease. III. Endocannabinoid effects on immune cells: implications for Inflammatory liver diseases. Am J Physiol Gastrointest Liver Physiol 2008;294(4):G850-4
   PubMed Web of Science ®Google Scholar
• Lotersztajn S, Teixeira-Clerc F, Julien B, et al. CB2 receptors as new therapeutic targets for liver diseases. Br J Pharmacol 2008;153(2):286-9
   PubMed Web of Science ®Google Scholar
• Teixeira-Clerc F, Belot MP, et al. Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration. Hepatology 2010;52(3):1046-59
   PubMed Web of Science ®Google Scholar
• Fouad AA, Jresat I. Therapeutic Potential of cannabidiol against ischemia/reperfusion liver injury in rats. Eur J Pharmacol 2011;670(1):216-23
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay P, Rajesh M, Horvath B, et al. Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death. Free Radic Biol Med 2011;50(10):1368-81
   PubMed Web of Science ®Google Scholar
• Caraceni P, Pertosa AM, Giannone F, et al. Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia. Gut 2009;58(8):1135-43
   PubMed Web of Science ®Google Scholar
• Rajesh M, Pan H, Mukhopadhyay P, et al. Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J Leukoc Biol 2007;82(6):1382-9
   PubMed Web of Science ®Google Scholar
• Edelstein CL, Ling H, Schrier RW. The nature of renal cell injury. Kidney Int 1997;51(5):1341-51
   PubMed Web of Science ®Google Scholar
• Feng L, Ke N, Cheng F, et al. The protective mechanism of ligustrazine against renal ischemia/reperfusion injury. J Surg Res 2011;166(2):298-305
   PubMed Web of Science ®Google Scholar
• Hosseini F, Naseri MK, Badavi M, et al. Effect of beta carotene on lipid peroxidation and antioxidant status following renal ischemia/reperfusion injury in rat. Scand J Clin Lab Invest 2010;70(4):259-63
   PubMed Web of Science ®Google Scholar
• Kizilgun M, Poyrazoglu Y, Oztas Y, et al. Beneficial effects of N-acetylcysteine and ebselen on renal ischemia/reperfusion injury. Ren Fail 2011;33(5):512-17
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Hagiwara S, Hidaka S, et al. The antioxidant EPC-K1 attenuates renal ischemia-reperfusion injury in a rat model. Am J Nephrol 2011;33(6):485-90
   PubMed Web of Science ®Google Scholar